| Literature DB >> 35975192 |
Naimur Rahman Chowdhury1, Mushaer Ahmed2, Priom Mahmud3, Sanjoy Kumar Paul4, Sharmine Akther Liza1.
Abstract
This study develops a vaccine supply chain (VSC) to ensure sustainable distribution during a global crisis in a developing economy. In this study, a multi-objective mixed-integer programming (MIP) model is formulated to develop the VSC, ensuring the entire network's economic performance. This is achieved by minimizing the overall cost of vaccine distribution and ensuring environmental and social sustainability by minimizing greenhouse gas (GHG) emissions and maximizing job opportunities in the entire network. The shelf-life of vaccines and the uncertainty associated with demand and supply chain (SC) parameters are also considered in this study to ensure the robustness of the model. To solve the model, two recently developed metaheuristics-namely, the multi-objective social engineering optimizer (MOSEO) and multi-objective feasibility enhanced particle swarm optimization (MOFEPSO) methods-are used, and their results are compared. Further, the Technique for Order Preference by Similarity to Ideal Solution (TOPSIS) model has been integrated into the optimization model to determine the best solution from a set of non-dominated solutions (NDSs) that prioritize environmental sustainability. The results are analyzed in the context of the Bangladeshi coronavirus disease (COVID-19) vaccine distribution systems. Numerical illustrations reveal that the MOSEO-TOPSIS model performs substantially better in designing the network than the MOFEPSO-TOPSIS model. Furthermore, the solution from MOSEO results in achieving better environmental sustainability than MOFEPSO with the same resources. Results also reflect that the proposed MOSEO-TOPSIS can help policymakers establish a VSC during a global crisis with enhanced economic, environmental, and social sustainability within the healthcare system.Entities:
Keywords: Healthcare system; Modeling and optimization; Supply chain management; Sustainability; Vaccine supply chain
Year: 2022 PMID: 35975192 PMCID: PMC9372915 DOI: 10.1016/j.jclepro.2022.133423
Source DB: PubMed Journal: J Clean Prod ISSN: 0959-6526 Impact factor: 11.072
Fig. 1Number of daily COVID-19 deaths in Bangladesh (as of January 10, 2022; DGHS, 2022).
List of existing literature on the relevant study.
| Authors | COVID-19 | VSC | SCN optimization | Developing country context |
|---|---|---|---|---|
| ✓ | ✓ | |||
| ✓ | ✓ | ✓ | ||
| ✓ | ✓ | ✓ | ||
| ✓ | ✓ | ✓ | ||
| ✓ | ✓ | ✓ | ||
| ✓ | ✓ | |||
| ✓ | ✓ | |||
| ✓ | ✓ | ✓ | ||
| ✓ | ✓ | |||
| ✓ | ✓ | ✓ | ||
| ✓ | ✓ | |||
| ✓ | ✓ | ✓ | ||
| ✓ | ✓ | |||
| ✓ | ✓ | ✓ | ||
| ✓ | ✓ | ✓ | ||
| ✓ | ||||
| ✓ | ✓ | |||
| ✓ | ✓ | |||
| ✓ | ✓ | |||
| ✓ | ✓ | ✓ | ||
| ✓ | ✓ | ✓ | ||
| ✓ | ✓ | ✓ | ||
| Current Study | ✓ | ✓ | ✓ | ✓ |
Fig. 2Schematic drawing of sustainable vaccine SCN in Bangladesh.
Problem scale of the SCN.
| Problem instance | Sets | |||||
|---|---|---|---|---|---|---|
| Suppliers | GACs | LDCs | VCs to be established | Periods | Vaccine Type | |
| SS1 | 8 | 4 | 6 | 40 | 2 | 4 |
| SS2 | 8 | 4 | 6 | 60 | 2 | 4 |
| MS1 | 16 | 8 | 10 | 100 | 2 | 4 |
| MS2 | 16 | 8 | 10 | 120 | 2 | 4 |
| LS1 | 20 | 10 | 14 | 150 | 2 | 4 |
| LS2 | 24 | 12 | 14 | 150 | 2 | 4 |
Distribution of parameters
| Parameter | Distribution | Parameter | Distribution |
|---|---|---|---|
| Uniform [1, 1.7] ($) | 105 Uniform [5, 20] ($) | ||
| Uniform [0.1, 0.3] ($) | Uniform [0.2, 0.4] ($) | ||
| Uniform [0.3, 0.9] ($) | 102 Uniform [15, 30] ($) | ||
| Uniform [6, 10] ($) (vaccine type 1) | Uniform [15, 30] ($) | ||
| Uniform [5, 7] ($) (vaccine type 2) | Uniform [0.2, 0.8] (MTCE) | ||
| Uniform [4, 6] ($) (vaccine type 3) | Uniform [5, 25] (MTCE) | ||
| Uniform [8, 10] ($) (vaccine type 4) | Uniform [0.2, 0.3] (%) | ||
| Uniform [.2, .6] ($) (packages) | 102 Uniform [40, 65] (ton) | ||
| Uniform [.1, .3] ($) (filling material) | 10 Uniform [5, 11] (ton) | ||
| 102 Uniform [0.3, 0.6] (MTCE) | Uniform [1, 4] | ||
| Uniform [0.1, 0.3] (MTCE) | |||
| 102 Uniform [1, 5] (pers.) | |||
| Uniform [15, 40] (ton) | |||
| 103 Uniform [0.8, 6] (ton) | |||
| 102 Uniform [2, 6] (ton) | |||
| Uniform [2, 5] (ton) |
Fig. 3Flowchart of the MOSEO methodology (Fathollahi-Fard et al., 2018).
Fig. 4Flowchart of the MOFEPSO methodology (Hasanoglu & Dolen, 2018)
Parameter values for the metaheuristics.
| Metaheuristic | Parameter | Value |
|---|---|---|
| MOSEO | Rate of collecting data, | 0.8 |
| Rate of connecting attacker, | ||
| Number of connections, | 200 | |
| MOFEPSO | Population size, | |
| Inertia weight, | 0.6 | |
| Personal acceleration coefficient, | ||
| Global acceleration coefficients, | ||
| Inflation rate, | 0.1 | |
| Mutation rate, | 0.1 |
Fig. 5Pareto-front for problem SS1.
Fig. 6(a) Convergence behavior of for instance SS1; (b) convergence behavior of for instance SS1; and (c) convergence behavior of for instance SS1.
Rank of solutions for SS1 from weightage normalized matrix in TOPSIS
| NDS point number in MOSEO | Rank | |||
|---|---|---|---|---|
| 1 | 3,000,561 | 6953.12 | 2183 | 14 |
| 2 | 3,049,758 | 6756.91329 | 2348 | 15 |
| 3 | 3,105,750 | 6743.42644 | 2458 | 16 |
| 4 | 3,434,155 | 6611.20239 | 2551 | 8 |
| 5 | 3,547,812 | 6604.59779 | 2596 | 11 |
| 6 | 3,609,143 | 6230.75263 | 2641 | 3 |
| 7 | 3,619,212 | 6218.316 | 2795 | 6 |
| 8 | 3,790,121 | 6037.2 | 2799 | 5 |
| 9 | 3,866,017 | 5031.041 | 2921 | 1 |
| 10 | 4,058,341 | 4397.094 | 3063 | 2 |
| 11 | 4,161,792 | 4001.35554 | 3066 | 7 |
| 12 | 4,358,945 | 3881.31487 | 3128 | 4 |
| 13 | 4,773,917 | 3531.99654 | 3165 | 9 |
| 14 | 4,978,880 | 3249.43681 | 3436 | 13 |
| 15 | 5,153,614 | 2989.48187 | 3762 | 10 |
Results and computational time for proposed algorithms.
| Problem instance | Objective function | MOSEO | MOFEPSO | ||||
|---|---|---|---|---|---|---|---|
| Optimal solution | T(s) | NDS | Optimal solution | T(s) | NDS | ||
| 3,866,017 | 18.3415 | 15 | 5,091,499 | 21.8157 | 14 | ||
| 5031 | 5316 | ||||||
| 2921 | 2521 | ||||||
| 4,658,934 | 22.2471 | 17 | 5,674,826 | 25.1419 | 19 | ||
| 5413 | 5608 | ||||||
| 3351 | 2996 | ||||||
| 7,522,336 | 29.4358 | 15 | 7,740,719 | 25.3875 | 14 | ||
| 8871 | 9151 | ||||||
| 8399 | 7990 | ||||||
| 9,162,302 | 35.0863 | 14 | 9,666,230 | 45.4219 | 15 | ||
| 8059 | 8307 | ||||||
| 8996 | 8807 | ||||||
| 10,529,269 | 59.5091 | 19 | 11,194,701 | 81.0981 | 13 | ||
| 12,105 | 14,868 | ||||||
| 11,456 | 10,041 | ||||||
| 13,662,302 | 65.9371 | 18 | 15,752,823 | 93.1853 | 11 | ||
| 14,319 | 16,148 | ||||||
| 12,071 | 11,479 | ||||||
Fig. 7Comparison of computational time for proposed algorithms.
Fig. 8Values of achieving.
Fig. 9Values of achieving.
Fig. 10Values of achieving.
Fig. 11Normalized NDS for problem SS1 in MOSEO.
Fig. 12Sustainability comparison between economic performance-focused VSC and sustainable VSC for MOSEO.
Sensitivity analysis of parameters.
| Inventory holding cost 50% increased | Inventory holding cost 50% decreased | Transportation cost 50% increased | Transportation cost 50% decreased | ||
|---|---|---|---|---|---|
| Opening cost ( | MOSEO | 0% | 1.215% | 21.456% | −19.504% |
| MOFEPSO | 0% | 1.341% | 22.621% | −20.516% | |
| Periodic operating cost( | MOSEO | 1.816% | −3.245% | −1.216% | 2.415% |
| MOFEPSO | 1.907% | −3.543% | −1.971% | 3.213% | |
| Transportation cost ( | MOSEO | 1.213% | 2.426% | – | – |
| MOFEPSO | 1.320% | 2.975% | – | – | |
| Assembly cost( | MOSEO | 0.126% | −0.512% | 0.216% | −0.212% |
| MOFEPSO | 0.167% | −0.759% | 0.117% | −0.229% | |
| Inventory holding cost ( | MOSEO | – | – | 1.821% | −1.241% |
| MOFEPSO | – | 1.912% | −2.531% |
| Indices | |
|---|---|
| S | Supplier; indexed by s |
| A | Global assembly center (GAC); indexed by |
| D | Local distribution center (LDC); indexed by |
| V | Vaccination center (VC); indexed by |
| R | Raw materials (vaccines, filling material, packages); indexed by |
| P | Packaged vaccine type p; indexed by |
| C | Capacity levels of new vaccine centers; indexed by |
| T | Time periods; indexed by |
| F | Vehicles used for transportation between LDCs and VCs; indexed by |
| N | Intervals in the discount schedule; indexed by |
| Parameters | |
| a penalty paid to VC | |
| cost of opening a VC | |
| inventory holding cost of each unit of raw material | |
| inventory holding cost of each unit of packaged vaccine | |
| unit assembly cost of packaged vaccine | |
| periodic operating cost for LDC | |
| unit price of raw material | |
| transportation cost of one unit of packaged vaccines from source node | |
| environmental impacts of VC | |
| environmental impacts of each unit of packaged vaccine | |
| environmental impacts of handling each unit of packaged vaccine | |
| environmental impacts of transporting one unit of each packaged vaccine from source node | |
| number of job creation if VC | |
| unemployment ratio in the region of VC | |
| quantity of packaged vaccine | |
| VC capacity | |
| supplier capacity | |
| capacity of vehicle | |
| lower bound of interval | |
| upper bound of interval | |
| a limitation on the number of established GACs | |
| a limitation on the number of established LDCs | |
| shelf-life of raw material | |
| shelf-life of packaged vaccine | |
| the required amount of raw material | |
| weight of the long-term costs | |
| weight of the mid-term costs | |
| δ | a sufficiently large number |
| Decision Variables | |
| 1 if center | |
| 1 if raw material | |
| 1 if LDC | |
| 1 if VC | |
| 1 if order quantity of GAC | |
| 1 if link | |
| inventory quantity of raw material | |
| inventory quantity of packaged vaccine | |
| quantity of order for raw material | |
| quantity of order for packaged vaccine | |
| a fraction of the order for packaged vaccine | |
| a fraction of the order for packaged vaccine | |
| a fraction of the order for packaged vaccine | |
| an auxiliary non-negative variable used for sub-tour elimination | |